BSD Medical gets FDA nod for microwave ablation system
The FDA has granted BSD Medical, a developer of microwave systems used in the treatment of cancer, a 510(k) clearance to market its MicroThermX-100 microwave ablation system (MTX-100).

The system was developed to provide treatments as a standalone therapy, rather than only in combination with other therapies, according to BSD.

The Salt Lake City-base company said its MTX-100 is a compact, mobile system that includes a computer, a microwave generator, single-patient-use disposable applicators and a proprietary thermistor-based temperature monitoring system.

The MTX-100 provides minimally invasive access to the target tissue and can be used in open surgical as well as in percutaneous ablation procedures performed by both surgeons and interventional radiologists.